AscentX Medical, Inc.
San Diego, CA · Founded 2017 · CIK 0001720591 · Biotech · Private
Injectable regenerative therapies using advanced soft tissue engineering
ascentxmedical.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $3.3M
- 4 Form D · Aug 2023
- 38 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,220,156 | |
| Private capital raised | Form D · SEC | $324,968 | |
| Private capital raised | Form D · SEC | $1,178,320 | |
| Private capital raised | Form D · SEC | $557,610 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1685 | CORE BIOTHERAPEUTICS INC | — | — |
| 1686 | HUMAN CELL CO | — | — |
| 1687 | SYMBIOTIX BIOTHERAPIES, INC. | — | — |
| 1688 | AscentX Medical, Inc. | — | $3.3M |
| 1689 | Revolve Biotechnologies, Inc. | — | — |
| 1690 | MPEX PHARMACEUTICALS, INC. | — | — |
| 1691 | iQure Pharma Inc. | — | $5.3M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Larry BragaDirector · Executive Officer
- David FrisciaDirector
- Glen LehmanDirector
- Gottfried LemperleDirector
- Stefan LemperleDirector · Executive Officer
- John LynchDirector
- Juergen SiemonsmeirDirector
- John StiskaDirector
- Yibo WangDirector
Patents
- Compositions And Methods Of Suspended Hyaluronic Acid Microspheres For Tissue And Skin Regeneration, Augmentation, Repair, And Adjustmentapplication
- Injection Apparatus For Long Distance Delivery Of Soft Tissue Bulking Agents Contaning Microspheresapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.